| scholarly article | Q13442814 |
| P50 | author | Wael H ElSawy | Q83181061 |
| Rajab AlZahrani | Q88807428 | ||
| Amani A Al-Rehaili | Q91260508 | ||
| Amal F Gharib | Q91713678 | ||
| Farah Anjum | Q91713680 | ||
| Khadiga Ahmed Ismail | Q60318284 | ||
| P2860 | cites work | Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis | Q90169896 |
| Prognostic significance of CIP2A expression in solid tumors: A meta-analysis | Q90467182 | ||
| Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression | Q91392965 | ||
| The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation | Q91578408 | ||
| Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5' AMP-activated protein kinase signalling in malignant cells | Q92214313 | ||
| Aberrant expression of vasculogenic mimicry, PRRX1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance | Q94050705 | ||
| Identification of PP2A complexes and pathways involved in cell transformation | Q24316472 | ||
| Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 | Q29614651 | ||
| Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth. | Q33712856 | ||
| Low Survival Rates of Oral and Oropharyngeal Squamous Cell Carcinoma | Q33790706 | ||
| CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis | Q34138056 | ||
| Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth | Q34812100 | ||
| Phosphatases: the new brakes for cancer development? | Q35504084 | ||
| Involvement of PP2A in viral and cellular transformation | Q36318172 | ||
| Regulation of cell adhesion by PP2A and SV40 small tumor antigen: an important link to cell transformation | Q36637948 | ||
| Multiple pathways regulated by the tumor suppressor PP2A in transformation | Q37105971 | ||
| Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma | Q37176111 | ||
| Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers | Q37381036 | ||
| The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells | Q37980870 | ||
| Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis | Q38026660 | ||
| Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target. | Q38160825 | ||
| Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands | Q38228491 | ||
| Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers | Q38335027 | ||
| All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase | Q38617799 | ||
| Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells | Q38702601 | ||
| Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy. | Q39026876 | ||
| Overview of the 8th Edition TNM Classification for Head and Neck Cancer. | Q39337270 | ||
| Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein | Q39541598 | ||
| Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma | Q43555438 | ||
| Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer | Q47381126 | ||
| The role of CIP2A in cancer: A review and update | Q47647975 | ||
| CIP2A expression and prognostic role in patients with esophageal adenocarcinoma | Q47832427 | ||
| Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer | Q50019901 | ||
| Developmental and light regulation of tumor suppressor protein PP2A in the retina. | Q50128117 | ||
| CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression. | Q51002208 | ||
| CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells | Q58788836 | ||
| Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer | Q59830301 | ||
| CIP2A overexpression in Taiwanese oral cancer patients | Q64070891 | ||
| P433 | issue | 1 | |
| P921 | main subject | oral squamous cell carcinoma | Q18553522 |
| P304 | page(s) | 21-26 | |
| P577 | publication date | 2020-03-01 | |
| P1433 | published in | Journal of cancer prevention | Q26841879 |
| P1476 | title | Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma | |
| P478 | volume | 25 |
Search more.